EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Organ‐Specific Cancer‐Associated Fibroblast Subtypes Across the Digestive System Linked to Cancer Hallmarks

Huaitao Wang, Takashi Semba, Atsuko Yonemura, Hiroshi Naito, Lingfeng Fu, Takuya Tajiri, Masaaki Iwatsuki, Takatsugu Ishimoto iD

Cancer Science · 2026-09 · 117 (9) · 2496-2508

DOI: 10.1111/cas.70435 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Science, online erschienen am 01.06.2026. Verfasst von Huaitao Wang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Division of Carcinogenesis, The Cancer Institute, Japanese Foundation for Cancer Research, Tokyo, Japan. Hauptthemen laut MEDLINE: Cancer-Associated Fibroblasts, Gastrointestinal Neoplasms, Adenocarcinoma. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Fusion Oriented REsearch for disruptive Science and Technology, Japan Agency for Medical Research and Development, Japan Society for the Promotion of Science.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cancer‐associated fibroblasts (CAFs) are major stromal components of the tumor microenvironment (TME) and play diverse roles in gastrointestinal (GI) cancer progression, immunity, and therapeutic resistance. However, the heterogeneity, tissue specificity, and clinical relevance of CAFs across GI cancers remain incompletely defined. We integrated 14 independent single‐cell RNA‐sequencing datasets comprising 239 GI adenocarcinoma samples to define the subtypes of CAFs. Machine learning–based deconvolution was applied to 18 bulk transcriptomic cohorts (3396 patients) to estimate CAF subtype abundance and assess prognostic associations by meta‐analysis. Functional states, differentiation trajectories, cell–cell communication, and spatial organization were analyzed using gene‐set enrichment, transcription factor activity inference, pseudotime modeling, ligand–receptor analysis, and spatial transcriptomics. We identified eight CAF subtypes with distinct transcriptional programs and organ‐specific distributions. Two myofibroblastic CAF subtypes (myCAF1 and myCAF2) were consistently associated with poor prognosis, characterized by extracellular matrix remodeling, TGF‐β signaling, hypoxia adaptation, and close crosstalk with immunosuppressive macrophages, as well as tumor cells displaying epithelial‐mesenchymal transition and hypoxia signatures. In contrast, inflammatory CAF (iCAF) 1 was associated with a favorable prognosis and increased infiltration of antitumor immune cells. Spatial transcriptomic analyses further revealed that distinct CAF subtypes preferentially occupied discrete spatial domains within the GI TME. Our study demonstrated that the functional state and spatial context of CAFs jointly affect tumor progression and outcomes in patients with GI cancers. myCAF‐driven stromal niches promote immune suppression and poor prognosis, whereas a balanced inflammatory CAF program may support antitumor immunity.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cancer-Associated FibroblastsGastrointestinal NeoplasmsAdenocarcinomaHumansTumor MicroenvironmentPrognosisGene Expression Regulation, NeoplasticSpatial TranscriptomicsGene Expression ProfilingOrgan SpecificityTranscriptomeEpithelial-Mesenchymal Transition

Stichwörter der Autor:innen

cancer‐associated fibroblastsgastrointestinal cancerpatient prognosissingle‐cell RNA sequencingspatial transcriptomics

Autor:innen und Institutionen

  • Division of Carcinogenesis, The Cancer Institute, Japanese Foundation for Cancer Research, Tokyo, Japan.
  • Department of Gastroenterological Surgery, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan.
  • Department of General Surgery, Shengjing Hospital of China Medical University, Shenyang, China.
  • International Research Center of Medical Sciences, Kumamoto University, Kumamoto, Japan.

ORCID-Profile: Takatsugu Ishimoto

Förderung

  • Fusion Oriented REsearch for disruptive Science and Technology
  • Japan Agency for Medical Research and Development
  • Japan Society for the Promotion of Science

Zitieren

APA

Wang, H., Semba, T., Yonemura, A., Naito, H., Fu, L., Tajiri, T., Iwatsuki, M., & Ishimoto, T. (2026). Organ‐Specific Cancer‐Associated Fibroblast Subtypes Across the Digestive System Linked to Cancer Hallmarks. Cancer Science, 117(9), 2496-2508. https://doi.org/10.1111/cas.70435

Vancouver

Wang H, Semba T, Yonemura A, Naito H, Fu L, Tajiri T, et al. Organ‐Specific Cancer‐Associated Fibroblast Subtypes Across the Digestive System Linked to Cancer Hallmarks. Cancer Science. 2026;117(9):2496-2508. doi:10.1111/cas.70435

BibTeX
@article{Wang2026,
  author = {Wang, Huaitao and Semba, Takashi and Yonemura, Atsuko and Naito, Hiroshi and Fu, Lingfeng and Tajiri, Takuya and Iwatsuki, Masaaki and Ishimoto, Takatsugu},
  title = {Organ‐Specific Cancer‐Associated Fibroblast Subtypes Across the Digestive System Linked to Cancer Hallmarks},
  journal = {Cancer Science},
  year = {2026},
  volume = {117},
  number = {9},
  pages = {2496--2508},
  doi = {10.1111/cas.70435}
}
Kostenlos starten →